Capsovision, Inc. (CV) fundamentals score
Capsovision is a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. It develops advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care.
Electromedical & Electrotherapeutic Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.1 out of 10, Mixed fundamentals
- Growth: 5.5/10
- Profitability: 2.5/10
- Financial health: 7.9/10
- Earnings quality: 8.4/10
- Valuation: 1.5/10
Scores are calculated from Capsovision, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10